This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability

Source
Federal Register
Link
View full story
Date
Dec 8, 2025
Summary
The Food and Drug Administration (FDA) has revoked an Emergency Use Authorization issued to Genentech, Inc. (Genentech) for Actemra (tocilizumab). The revocation is effective August 8, 2025.
Tagged as
COVID-19 · Legislation and regulations · Pharmacy and prescription drugs